200 related articles for article (PubMed ID: 28373901)
1. Reperfusion Therapy with Rapamycin Attenuates Myocardial Infarction through Activation of AKT and ERK.
Filippone SM; Samidurai A; Roh SK; Cain CK; He J; Salloum FN; Kukreja RC; Das A
Oxid Med Cell Longev; 2017; 2017():4619720. PubMed ID: 28373901
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of mammalian target of rapamycin protects against reperfusion injury in diabetic heart through STAT3 signaling.
Das A; Salloum FN; Filippone SM; Durrant DE; Rokosh G; Bolli R; Kukreja RC
Basic Res Cardiol; 2015 May; 110(3):31. PubMed ID: 25911189
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes.
Khan S; Salloum F; Das A; Xi L; Vetrovec GW; Kukreja RC
J Mol Cell Cardiol; 2006 Aug; 41(2):256-64. PubMed ID: 16769083
[TBL] [Abstract][Full Text] [Related]
4. Mammalian target of rapamycin inhibition attenuates myocardial ischaemia-reperfusion injury in hypertrophic heart.
Ma LL; Ma X; Kong FJ; Guo JJ; Shi HT; Zhu JB; Zou YZ; Ge JB
J Cell Mol Med; 2018 Mar; 22(3):1708-1719. PubMed ID: 29314656
[TBL] [Abstract][Full Text] [Related]
5. STAT3-miR-17/20 signalling axis plays a critical role in attenuating myocardial infarction following rapamycin treatment in diabetic mice.
Samidurai A; Roh SK; Prakash M; Durrant D; Salloum FN; Kukreja RC; Das A
Cardiovasc Res; 2020 Nov; 116(13):2103-2115. PubMed ID: 31738412
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin protects against myocardial ischemia-reperfusion injury through JAK2-STAT3 signaling pathway.
Das A; Salloum FN; Durrant D; Ockaili R; Kukreja RC
J Mol Cell Cardiol; 2012 Dec; 53(6):858-69. PubMed ID: 22999860
[TBL] [Abstract][Full Text] [Related]
7. Hypertrophied myocardium is vulnerable to ischemia/reperfusion injury and refractory to rapamycin-induced protection due to increased oxidative/nitrative stress.
Ma LL; Li Y; Yin PP; Kong FJ; Guo JJ; Shi HT; Zhu JB; Zou YZ; Ge JB
Clin Sci (Lond); 2018 Jan; 132(1):93-110. PubMed ID: 29175946
[TBL] [Abstract][Full Text] [Related]
8. Chronic treatment with novel nanoformulated micelles of rapamycin, Rapatar, protects diabetic heart against ischaemia/reperfusion injury.
Samidurai A; Salloum FN; Durrant D; Chernova OB; Kukreja RC; Das A
Br J Pharmacol; 2017 Dec; 174(24):4771-4784. PubMed ID: 28967097
[TBL] [Abstract][Full Text] [Related]
9. Evidence that the MEK/ERK but not the PI3K/Akt pathway is required for protection from myocardial ischemia-reperfusion injury by 3',4'-dihydroxyflavonol.
Thomas CJ; Lim NR; Kedikaetswe A; Yeap YY; Woodman OL; Ng DC; May CN
Eur J Pharmacol; 2015 Jul; 758():53-9. PubMed ID: 25820159
[TBL] [Abstract][Full Text] [Related]
10. Curcumin protects against regional myocardial ischemia/reperfusion injury through activation of RISK/GSK-3β and inhibition of p38 MAPK and JNK.
Jeong CW; Yoo KY; Lee SH; Jeong HJ; Lee CS; Kim SJ
J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):387-94. PubMed ID: 22396328
[TBL] [Abstract][Full Text] [Related]
11. Insulin protects isolated hearts from ischemia/reperfusion injury: cross-talk between PI3-K/Akt and JNKs.
Liu HT; Zhang HF; Si R; Zhang QJ; Zhang KR; Guo WY; Wang HC; Gao F
Sheng Li Xue Bao; 2007 Oct; 59(5):651-9. PubMed ID: 17940706
[TBL] [Abstract][Full Text] [Related]
12. Electroacupuncture preconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting mitophagy mediated by the mTORC1-ULK1-FUNDC1 pathway.
Xiao Y; Chen W; Zhong Z; Ding L; Bai H; Chen H; Zhang H; Gu Y; Lu S
Biomed Pharmacother; 2020 Jul; 127():110148. PubMed ID: 32344255
[TBL] [Abstract][Full Text] [Related]
13. Activation of transient receptor potential vanilloid 1 protects the heart against apoptosis in ischemia/reperfusion injury through upregulating the PI3K/Akt signaling pathway.
Jiang XX; Liu GY; Lei H; Li ZL; Feng QP; Huang W
Int J Mol Med; 2018 Mar; 41(3):1724-1730. PubMed ID: 29286076
[TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin-3-gallate, a green tea catechin, protects the heart against regional ischemia-reperfusion injuries through activation of RISK survival pathways in rats.
Kim SJ; Li M; Jeong CW; Bae HB; Kwak SH; Lee SH; Lee HJ; Heo BH; Yook KB; Yoo KY
Arch Pharm Res; 2014 Aug; 37(8):1079-85. PubMed ID: 24307060
[TBL] [Abstract][Full Text] [Related]
15. Cross-talk between the survival kinases during early reperfusion: its contribution to ischemic preconditioning.
Hausenloy DJ; Mocanu MM; Yellon DM
Cardiovasc Res; 2004 Aug; 63(2):305-12. PubMed ID: 15249188
[TBL] [Abstract][Full Text] [Related]
16. Activation of p38 mitogen-activated protein kinase abolishes insulin-mediated myocardial protection against ischemia-reperfusion injury.
Chai W; Wu Y; Li G; Cao W; Yang Z; Liu Z
Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E183-9. PubMed ID: 18003719
[TBL] [Abstract][Full Text] [Related]
17. Trimetazidine protects against cardiac ischemia/reperfusion injury via effects on cardiac miRNA‑21 expression, Akt and the Bcl‑2/Bax pathway.
Ma N; Bai J; Zhang W; Luo H; Zhang X; Liu D; Qiao C
Mol Med Rep; 2016 Nov; 14(5):4216-4222. PubMed ID: 27666568
[TBL] [Abstract][Full Text] [Related]
18. The protective effect of trimetazidine on myocardial ischemia/reperfusion injury through activating AMPK and ERK signaling pathway.
Liu Z; Chen JM; Huang H; Kuznicki M; Zheng S; Sun W; Quan N; Wang L; Yang H; Guo HM; Li J; Zhuang J; Zhu P
Metabolism; 2016 Mar; 65(3):122-30. PubMed ID: 26892523
[TBL] [Abstract][Full Text] [Related]
19. Ischemia-reperfusion induces glomerular and tubular activation of proinflammatory and antiapoptotic pathways: differential modulation by rapamycin.
Loverre A; Ditonno P; Crovace A; Gesualdo L; Ranieri E; Pontrelli P; Stallone G; Infante B; Schena A; Di Paolo S; Capobianco C; Ursi M; Palazzo S; Battaglia M; Selvaggi FP; Schena FP; Grandaliano G
J Am Soc Nephrol; 2004 Oct; 15(10):2675-86. PubMed ID: 15466272
[TBL] [Abstract][Full Text] [Related]
20. Ischemic but not mechanical preconditioning attenuates ischemia/reperfusion induced myocardial apoptosis in anaesthetized rabbits: the role of Bcl-2 family proteins and ERK1/2.
Lazou A; Iliodromitis EK; Cieslak D; Voskarides K; Mousikos S; Bofilis E; Kremastinos DT
Apoptosis; 2006 Dec; 11(12):2195-204. PubMed ID: 17051325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
